811 Allelic variation in Human Leukocyte Antigen class II genes is associated with pneumonitis risk in cancer patients treated with immune checkpoint inhibitors

• Christine Spencer,
• Shahneen Sandhu,
• Ira Mellman,
• Zia Khan,
• Julie Hunkapiller,
• Samantha Bucktrout,
• Ashis Saha,
• Jonathan Carroll,
• Claudia Yanez Arellano,
• Nicholas Bayless,
• Leonardo Nissola,
• Roslyn Wallace,
• Rajat Mohindra,
• G. Scott Chandler,
• Christian Hammer

Affiliations

Christine Spencer

3Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA

Shahneen Sandhu

Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Ira Mellman

Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA

Zia Khan

Department of Human Genetics, Genentech, Inc, South San Francisco, California, USA

Julie Hunkapiller

1Genentech, South San Francisco, CA, United States

Samantha Bucktrout

Parker Institute for Cancer Immunotherapy, San Francisco, California, USA

Ashis Saha

1Genentech, South San Francisco, CA, United States

Jonathan Carroll

1Genentech, South San Francisco, CA, United States

Claudia Yanez Arellano

3F. Hoffmann-La Roche, Basel, Switzerland

Nicholas Bayless

2Parker Institute f. Cancer Immunotherapy, San Francisco, CA, United States

Leonardo Nissola

2Parker Institute f. Cancer Immunotherapy, San Francisco, CA, United States

Roslyn Wallace

4Peter MacCallum Cancer Centre, Melbourne, Australia

Rajat Mohindra

3F. Hoffmann-La Roche, Basel, Switzerland

G. Scott Chandler

3F. Hoffmann-La Roche, Basel, Switzerland

Christian Hammer

1Genentech, South San Francisco, CA, United States